US Broker Ratings

Revolution Medicines, Inc. (RVMD) Stock Analysis: Biotech Heavyweight with 24% Potential Upside

Revolution Medicines, Inc. (RVMD), a prominent player in the biotechnology sector, is making waves with its promising pipeline of targeted therapies aimed at RAS-addicted cancers. With a staggering market capitalization..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: 72.83% Potential Upside Captivates Investors

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) has long stood as a beacon in the biotechnology sector, renowned for its dedication to developing therapies for rare, life-threatening diseases. With a market capitalization..

Royalty Pharma plc (RPRX) Investor Outlook: Strong Buy Ratings and Solid Growth Prospects

Royalty Pharma plc (NASDAQ: RPRX) is a prominent player in the biotechnology sector, with a unique focus on acquiring biopharmaceutical royalties and funding innovation across diverse therapeutic areas. With a..

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 38.86% Potential Upside in Biotech Innovation

Nuvalent, Inc. (NASDAQ: NUVL) stands at the forefront of the biotechnology sector, with a significant market cap of $8.08 billion, a testament to its potential in transforming cancer therapies. Headquartered..

Repligen Corporation (RGEN) Stock Analysis: Assessing a Potential 73.75% Upside in the Bioprocessing Innovator

In the ever-evolving landscape of the healthcare sector, Repligen Corporation (NASDAQ: RGEN) stands out as a pioneering force in the medical instruments and supplies industry. With a market capitalization of..

Stryker Corporation (SYK) Stock Analysis: Unveiling a 26.92% Upside Potential Amid Robust Analyst Support

Stryker Corporation (NYSE: SYK), a titan in the healthcare sector, is renowned for its extensive range of medical devices and technologies. With a market capitalization of $117.6 billion, the company..

Becton, Dickinson and Company (BDX) Stock Analysis: Unveiling a 27.75% Potential Upside

For investors searching for stability coupled with potential growth in the healthcare sector, Becton, Dickinson and Company (NYSE: BDX) presents an intriguing opportunity. With a market capitalization of $39.53 billion,..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring a 34% Potential Upside for Investors

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, presents a compelling opportunity for investors seeking growth in the diagnostics..

Zoetis Inc. (ZTS) Stock Analysis: Exploring the 72.70% Potential Upside

Zoetis Inc. (NYSE: ZTS) is a formidable player in the healthcare sector, specializing in the animal health industry. Headquartered in Parsippany, New Jersey, Zoetis is renowned for its comprehensive portfolio..

Gilead Sciences, Inc. (GILD) Stock Analysis: Evaluating a 21.90% Upside Potential for Investors

Gilead Sciences, Inc. (NASDAQ: GILD), a prominent player in the healthcare sector, is capturing the attention of investors with a compelling growth narrative and a potential upside of 21.90%. As..

HCA Healthcare, Inc. (HCA): Investor Outlook Highlights 21.30% Potential Upside

HCA Healthcare, Inc. (NYSE: HCA) continues to be a focal point for investors in the medical care facilities industry, thanks to its substantial market cap of $93.84 billion and a..

Quest Diagnostics (DGX) Investor Outlook: Unpacking a 19.63% Potential Upside

For investors eyeing the healthcare sector, Quest Diagnostics Incorporated (NYSE: DGX) presents a compelling opportunity, underpinned by a significant 19.63% potential upside. This market leader in diagnostic testing and services..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Biotech Powerhouse with 35.77% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is making waves in the biotechnology sector with its innovative approach to RNA-targeted medicines. As a commercial-stage company headquartered in Carlsbad, California, Ionis is at..

The Cigna Group (CI) Investor Outlook: Exploring a 19.36% Upside Potential

As individual investors sift through an ever-evolving healthcare landscape, The Cigna Group (NYSE: CI) stands out with a promising potential upside of 19.36% according to the latest analyst ratings. This..

The Cooper Companies, Inc. (COO)

⚠️ No article content returned.

..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 41.84% Potential Upside in the Biopharma Sector

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the healthcare sector, has captured investor interest with its substantial potential upside of 41.84%, according to recent analyst ratings. Headquartered in Barcelona,..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating Challenges in the Healthcare Sector

Molina Healthcare Inc (NYSE: MOH) is a significant player in the healthcare plans industry, primarily focused on providing managed healthcare services to low-income families and individuals through Medicaid and Medicare..

Novo Nordisk A/S (NVO) Stock Analysis: A Healthcare Giant with Strong Revenue Growth and Dividend Potential

Novo Nordisk A/S (NVO), a leading player in the healthcare sector, particularly in the drug manufacturing industry, continues to capture investor attention with its robust financial performance and market position...

Labcorp Holdings Inc. (LH) Stock Analysis: A 23.83% Upside Potential Beckons Investors

Labcorp Holdings Inc. (NYSE: LH), a titan in the Diagnostics & Research industry, commands attention with its robust market cap of $20.53 billion. As a key player in the healthcare..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Unpacking a 17.71% Potential Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a stalwart in the medical devices industry, presents a compelling opportunity for investors looking to capitalize on its significant potential upside. With a market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds